Recall of Lipitor Issued for 38K More Bottles Over Bad Smell

About 38,000 more bottles of Lipitor will be recalled due to possible contamination with a pesticide that causes the bottles of the cholesterol drug to have a bad smell or musty odor. 

An additional two lots of the medication were added to a prior recall of Lipitor, which was first announced in August and previously expanded last month for the same reasons. This brings the total number of Lipitor bottles affected by the recall to about 369,000.

Pfizer, Inc. announced its intent to expand the recall in a press release (pdf) on October 30, after receiving two customer reports of musty odors from the two additional lots. However, the company has not yet released the lot numbers for the most recently recalled bottles of 40 mg tablets.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

The odor has been identified as 2, 4, 6 tribromoanisole, or TBA; a pesticide used to treat wood pallets where medicines are often stored. The same substance led to a massive recall of Johnson & Johnson drugs late last year, including Tylenol, Motrin, and Benadryl. In that case, the substance was reported to make people ill. Pfizer says the physical effects of the contaminated Lipitor are minimal.

Lipitor (Atorvastatin) was approved by FDA in December 1996 for use in lowering cholesterol. It is a member of a class of drugs called statins and works by inhibiting an enzyme in the liver that takes part in cholesterol production. Lipitor brought in $12.4 billion in sales for Pfizer in 2008.

The recall comes shortly after the U.S. Department of Justice (DOJ) filed a brief in support of a Lipitor whistleblower lawsuit by a former company executive who says that Pfizer misled doctors about the health benefits of the drug. Pfizer has called for the lawsuit to be dismissed, but the DOJ brief attacked the call for dismissal on a number of grounds. The DOJ declined to join the lawsuit, however. 

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward
Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward (Posted yesterday)

A federal judge has cleared Gardasil lawsuits to move forward, after paring down plaintiffs' claims to those alleging Merck either failed to warn, or fraudulently concealed, the HPV vaccine's risks from the medical community.